Next Article in Journal
Three Bianthraquinone Derivatives from the Mangrove Endophytic Fungus Alternaria sp. ZJ9-6B from the South China Sea
Previous Article in Journal
Neuroprotective Effects of Marine Algae
 
 
Article

Antiproliferative Activity of Violaxanthin Isolated from Bioguided Fractionation of Dunaliella tertiolecta Extracts

1
University of La Rochelle, UMR CNRS 6250 LIENSs, F-17042 La Rochelle, France
2
IFREMER Laboratory PBA, IFREMER Centre Nantes, F-44311 Nantes, France
3
Department LASER, CHU Nantes, F-44093 Nantes, France
*
Author to whom correspondence should be addressed.
Mar. Drugs 2011, 9(5), 819-831; https://doi.org/10.3390/md9050819
Received: 29 March 2011 / Revised: 27 April 2011 / Accepted: 4 May 2011 / Published: 11 May 2011
Dunaliella tertiolecta (DT) was chemically investigated to isolate molecules inhibiting cancer cell proliferation and inducing apoptosis in vitro. The potency to inhibit cell growth was used for the bio-guided fractionation and isolation of active compounds using chromatographic techniques. The DT dichloromethane extract exhibited a strong anti-proliferative activity on MCF-7 and LNCaP cells, and was further fractionated and sub-fractionated by RP-HPLC. High resolution mass spectrometry and spectrophotometric analysis unequivocally identified violaxanthin as the most antiproliferative molecule present in DT DCM extract. Violaxanthin purified from DT induced MCF-7 dose-dependent growth inhibition in continuous and discontinuous treatments, at concentrations as low as 0.1 µg·mL−1 (0.17 µM). Phosphatidylserine exposure, typical of early apoptosis, was observed after 48 h treatment at 8 µg·mL1 (13.3 µM) but no DNA fragmentation, characteristic of late apoptosis steps, could be detected even after 72 h treatment at 40 µg·mL1 (66.7 µM). Taken together, our results demonstrate the strong antiproliferative activity of violaxanthin on one human mammary cancer cell line, and suggest that studying the pharmacology of violaxanthin and pharmacomodulated derivatives on cancer cells may allow potent antiproliferative drugs to be obtained. View Full-Text
Keywords: pigments; microalgae; Dunaliella; violaxanthin; carotenoid; cancer; apoptosis pigments; microalgae; Dunaliella; violaxanthin; carotenoid; cancer; apoptosis
Show Figures

MDPI and ACS Style

Pasquet, V.; Morisset, P.; Ihammouine, S.; Chepied, A.; Aumailley, L.; Berard, J.-B.; Serive, B.; Kaas, R.; Lanneluc, I.; Thiery, V.; Lafferriere, M.; Piot, J.-M.; Patrice, T.; Cadoret, J.-P.; Picot, L. Antiproliferative Activity of Violaxanthin Isolated from Bioguided Fractionation of Dunaliella tertiolecta Extracts. Mar. Drugs 2011, 9, 819-831. https://doi.org/10.3390/md9050819

AMA Style

Pasquet V, Morisset P, Ihammouine S, Chepied A, Aumailley L, Berard J-B, Serive B, Kaas R, Lanneluc I, Thiery V, Lafferriere M, Piot J-M, Patrice T, Cadoret J-P, Picot L. Antiproliferative Activity of Violaxanthin Isolated from Bioguided Fractionation of Dunaliella tertiolecta Extracts. Marine Drugs. 2011; 9(5):819-831. https://doi.org/10.3390/md9050819

Chicago/Turabian Style

Pasquet, Virginie, Perrine Morisset, Said Ihammouine, Amandine Chepied, Lucie Aumailley, Jean-Baptiste Berard, Benoit Serive, Raymond Kaas, Isabelle Lanneluc, Valerie Thiery, Mathieu Lafferriere, Jean-Marie Piot, Thierry Patrice, Jean-Paul Cadoret, and Laurent Picot. 2011. "Antiproliferative Activity of Violaxanthin Isolated from Bioguided Fractionation of Dunaliella tertiolecta Extracts" Marine Drugs 9, no. 5: 819-831. https://doi.org/10.3390/md9050819

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop